Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice

被引:104
作者
Dumont, Magali [1 ]
Stack, Cliona [1 ]
Elipenahli, Ceyhan [1 ]
Jainuddin, Shari [1 ]
Gerges, Meri [1 ]
Starkova, Natalia N. [1 ]
Yang, Lichuan [1 ]
Starkov, Anatoly A. [1 ]
Beal, Flint [1 ]
机构
[1] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA
关键词
tauopathy; exploration; tangles; LIPID-PEROXIDATION PRODUCT; MOUSE MODEL; NEURODEGENERATIVE TAUOPATHIES; ALZHEIMERS-DISEASE; PROTEIN; CELLS;
D O I
10.1096/fj.11-186650
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abnormal tau accumulation can lead to the development of neurodegenerative diseases. P301S mice overexpress the human tau mutated gene, resulting in tau hyperphosphorylation and tangle formation. Mice also develop synaptic deficits and microglial activation prior to any neurodegeneration and tangles. Oxidative stress can also affect tauopathy. We studied the role of oxidative stress in relationship to behavioral abnormalities and disease progression in P301S mice at 2, 7, and 10 mo of age. At 7 mo of age, P301S mice had behavioral abnormalities, such as hyperactivity and disinhibition. At the same age, we observed increased carbonyls in P301S mitochondria (similar to 215 and 55% increase, males/females), and deregulation in the activity and content of mitochondrial enzymes involved in reactive oxygen species formation and energy metabolism, such as citrate synthase (similar to 19 and similar to 5% decrease, males/females), MnSOD (similar to 16% decrease, males only), cytochrome C (similar to 19% decrease, females only), and cytochrome C oxidase (similar to 20% increase, females only). These changes in mitochondria proteome appeared before tau hyperphosphorylation and tangle formation, which were observed at 10 mo and were associated with GSK3 beta activation. At that age, mitochondria proteome deregulation became more apparent in male P301S mitochondria. The data strongly suggest that oxidative stress and mitochondrial abnormalities appear prior to tau pathology.-Dumont, M., Stack, C., Elipenahli, C., Jainuddin, S., Gerges, M., Starkova, M. N., Yang, L., Starkov, A. A., Beal, F. Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. FASEB J. 25, 4063-4072 (2011). www.fasebj.org
引用
收藏
页码:4063 / 4072
页数:10
相关论文
共 50 条
  • [21] Behavioral Improvement after Chronic Administration of Coenzyme Q10 in P301S Transgenic Mice
    Elipenahli, Ceyhan
    Stack, Cliona
    Jainuddin, Shari
    Gerges, Meri
    Yang, Lichuan
    Starkov, Anatoly
    Beal, M. Flint
    Dumont, Magali
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 28 (01) : 173 - 182
  • [22] Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein
    Allen, B
    Ingram, E
    Takao, M
    Smith, MJ
    Jakes, R
    Virdee, K
    Yoshida, H
    Holzer, M
    Craxton, M
    Emson, PC
    Atzori, C
    Migheli, A
    Crowther, RA
    Ghetti, B
    Spillantini, MG
    Goedert, M
    JOURNAL OF NEUROSCIENCE, 2002, 22 (21) : 9340 - 9351
  • [23] Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
    Valencia, Antonio
    Bieber, Veronica L. Reinhart
    Bajrami, Bekim
    Marsh, Galina
    Hamann, Stefan
    Wei, Ru
    Ling, Karen
    Rigo, Frank
    Arnold, H. Moore
    Golonzhka, Olga
    Hering, Heike
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [24] Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
    Schweighauser, Manuel
    Murzin, Alexey G.
    Macdonald, Jennifer
    Lavenir, Isabelle
    Crowther, R. Anthony
    Scheres, Sjors H. W.
    Goedert, Michel
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [25] Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
    Eckenweber, Florian
    Medina-Luque, Jose
    Blume, Tanja
    Sacher, Christian
    Biechele, Gloria
    Wind, Karin
    Deussing, Maximilian
    Briel, Nils
    Lindner, Simon
    Boening, Guido
    von Ungern-Sternberg, Barbara
    Unterrainer, Marcus
    Albert, Nathalie L.
    Zwergal, Andreas
    Levin, Johannes
    Bartenstein, Peter
    Cumming, Paul
    Rominger, Axel
    Hoeglinger, Guenter U.
    Herms, Jochen
    Brendel, Matthias
    JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [26] TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
    Jiang, Teng
    Zhang, Ying-Dong
    Chen, Qi
    Gao, Qing
    Zhu, Xi-Chen
    Zhou, Jun-Shan
    Shi, Jian-Quan
    Lu, Huan
    Tan, Lan
    Yu, Jin-Tai
    NEUROPHARMACOLOGY, 2016, 105 : 196 - 206
  • [27] Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
    Chalermpalanupap, Termpanit
    Schroeder, Jason P.
    Rorabaugh, Jacki M.
    Liles, L. Cameron
    Lah, James J.
    Levey, Allan I.
    Weinshenker, David
    JOURNAL OF NEUROSCIENCE, 2018, 38 (01) : 74 - 92
  • [28] Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy
    Watt, Georgia
    Przybyla, Magdalena
    Zak, Valeria
    van Eersel, Janet
    Ittner, Arne
    Ittner, Lars M.
    Karl, Tim
    NEUROSCIENCE, 2020, 431 : 166 - 175
  • [29] Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice
    Giannopoulos, Phillip F.
    Chiu, Jian
    Pratico, Domenico
    AGING CELL, 2018, 17 (03)
  • [30] Tau Pathology is Present In Vivo and Develops In Vitro in Sensory Neurons from Human P301S Tau Transgenic Mice: A System for Screening Drugs against Tauopathies
    Mellone, Manuela
    Kestoras, Dimitra
    Andrews, Melissa R.
    Dassie, Elisa
    Crowther, R. Anthony
    Stokin, Gorazd B.
    Tinsley, Jon
    Horne, Graeme
    Goedert, Michel
    Tolkovsky, Aviva M.
    Spillantini, Maria Grazia
    JOURNAL OF NEUROSCIENCE, 2013, 33 (46) : 18175 - 18189